rs770002854
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005751.5(AKAP9):c.5639G>A(p.Arg1880His) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,612,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1880C) has been classified as Uncertain significance.
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Publications
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- long QT syndrome 11Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AKAP9 | NM_005751.5 | c.5639G>A | p.Arg1880His | missense_variant | Exon 23 of 50 | ENST00000356239.8 | NP_005742.4 | |
| AKAP9 | NM_147185.3 | c.5639G>A | p.Arg1880His | missense_variant | Exon 23 of 50 | NP_671714.1 | ||
| AKAP9 | NM_001379277.1 | c.284G>A | p.Arg95His | missense_variant | Exon 2 of 29 | NP_001366206.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AKAP9 | ENST00000356239.8 | c.5639G>A | p.Arg1880His | missense_variant | Exon 23 of 50 | 1 | NM_005751.5 | ENSP00000348573.3 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151782Hom.: 0 Cov.: 29 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 250964 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1460718Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 726684 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151782Hom.: 0 Cov.: 29 AF XY: 0.0000135 AC XY: 1AN XY: 74082 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1880 of the AKAP9 protein (p.Arg1880His). This variant is present in population databases (rs770002854, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with AKAP9-related conditions. ClinVar contains an entry for this variant (Variation ID: 412027). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R1880H variant (also known as c.5639G>A), located in coding exon 23 of the AKAP9 gene, results from a G to A substitution at nucleotide position 5639. The arginine at codon 1880 is replaced by histidine, an amino acid with highly similar properties. Another alteration affecting the same amino acid, p.R1880P (c.5639G>C), has been reported in association with long QT syndrome (Proost D et al. J Mol Diagn, 2017 May;19:445-459). This amino acid position is well conserved in available vertebrate species; however, histidine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at